PROTHEA TECHNOLOGIES Trademark

Trademark Overview


On Wednesday, January 29, 2025, a trademark application was filed for PROTHEA TECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the PROTHEA TECHNOLOGIES trademark a serial number of 79419298. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, May 5, 2026. This trademark is owned by Prothea Technologies Ltd. The PROTHEA TECHNOLOGIES trademark is filed in the Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services; medical services relating to cancer; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment, utilisation review, counselling, and patient networking; consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment, utilisation review; computer information services, namely, providing information on cancer and other diseases, oncology and disease management via a global computer network; medical services, namely, medical diagnostic testing, monitoring and reporting services; information, consultancy and advisory services relating to the aforesaid services.

Medical devices for use in treating or diagnosing lung cancer; medical apparatus, namely, microendoscopes, spectroscopes, fluorescence spectrometer, fluorescence-based diagnostic imager, laser ablation catheter; medical devices for use in diagnosing cancer; medical apparatus and instruments for the treatment of cancer; surgical apparatus and instruments; diagnostic apparatus for medical purposes for use in diagnosing lung cancer ; medical testing kits for diagnosing lung cancer; oncology instruments for medical use in treatment of lung cancer ; apparatus for applying laser radiation for medical purposes; diagnostic imaging apparatus for medical use; apparatus for analysing images for medical use; parts and fittings for all of the aforesaid goods

Scientific services, namely, processing of fluorescent images; technological services, namely, processing of fluorescent images; scientific research; technological research in the field of fluorescence-based imaging; scientific and technological services, namely, research and design in the field of fluorescence-based imaging; medical research services; scientific research in the field of oncology; conducting and directing medical and scientific research in the field of cancer prevention, causes, symptoms, diagnosis, detection, treatment and prevention; design and development of image processing software; design and development of computer software for use with medical technology; electronic scanning of images; platform as a service (PaaS) featuring software platforms for transmission of images; information, consultancy and advisory services relating to the aforesaid services; all of the preceding in the field of imaging and ablation in the detection and treatment of cancer
prothea technologies

General Information


Serial Number79419298
Word MarkPROTHEA TECHNOLOGIES
Filing DateWednesday, January 29, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, May 5, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical services; medical services relating to cancer; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment, utilisation review, counselling, and patient networking; consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment, utilisation review; computer information services, namely, providing information on cancer and other diseases, oncology and disease management via a global computer network; medical services, namely, medical diagnostic testing, monitoring and reporting services; information, consultancy and advisory services relating to the aforesaid services.
Goods and ServicesMedical devices for use in treating or diagnosing lung cancer; medical apparatus, namely, microendoscopes, spectroscopes, fluorescence spectrometer, fluorescence-based diagnostic imager, laser ablation catheter; medical devices for use in diagnosing cancer; medical apparatus and instruments for the treatment of cancer; surgical apparatus and instruments; diagnostic apparatus for medical purposes for use in diagnosing lung cancer ; medical testing kits for diagnosing lung cancer; oncology instruments for medical use in treatment of lung cancer ; apparatus for applying laser radiation for medical purposes; diagnostic imaging apparatus for medical use; apparatus for analysing images for medical use; parts and fittings for all of the aforesaid goods
Goods and ServicesScientific services, namely, processing of fluorescent images; technological services, namely, processing of fluorescent images; scientific research; technological research in the field of fluorescence-based imaging; scientific and technological services, namely, research and design in the field of fluorescence-based imaging; medical research services; scientific research in the field of oncology; conducting and directing medical and scientific research in the field of cancer prevention, causes, symptoms, diagnosis, detection, treatment and prevention; design and development of image processing software; design and development of computer software for use with medical technology; electronic scanning of images; platform as a service (PaaS) featuring software platforms for transmission of images; information, consultancy and advisory services relating to the aforesaid services; all of the preceding in the field of imaging and ablation in the detection and treatment of cancer
NOT AVAILABLETECHNOLOGIES

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, March 20, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 20, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 20, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProthea Technologies Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, March 20, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 21, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 21, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, July 9, 2025ASSIGNED TO EXAMINER
Friday, July 11, 2025NON-FINAL ACTION WRITTEN
Saturday, July 12, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, July 18, 2025LETTER OF PROTEST EVIDENCE FORWARDED
Thursday, August 7, 2025LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN
Tuesday, August 12, 2025NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, September 17, 2025NON-FINAL ACTION WRITTEN
Thursday, September 18, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 18, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 18, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 6, 2025REFUSAL PROCESSED BY MPU
Thursday, November 6, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 22, 2025LIMITATION OF GOODS RECEIVED FROM IB
Monday, November 24, 2025REFUSAL PROCESSED BY IB
Tuesday, May 5, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 5, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 5, 2026TEAS/EMAIL CORRESPONDENCE ENTERED